Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR+162.0%
5Y CAGR+51.4%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+162.0%/yr
Quarterly compound
5Y CAGR
+51.4%/yr
Recent acceleration
Percentile
P85
Within normal range
vs 5Y Ago
8x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 23.43% |
| Q2 2025 | 6.90% |
| Q1 2025 | 6.44% |
| Q4 2024 | -9.84% |
| Q3 2024 | -3.98% |
| Q2 2024 | -12.96% |
| Q1 2024 | 39.49% |
| Q4 2023 | 5.93% |
| Q3 2023 | 66.34% |
| Q2 2023 | -11.67% |
| Q1 2023 | 58.42% |
| Q4 2022 | 23.75% |
| Q3 2022 | 1.30% |
| Q2 2022 | 1.29% |
| Q1 2022 | 1.20% |
| Q4 2021 | 208.50% |
| Q3 2021 | -5.81% |
| Q2 2021 | -0.25% |
| Q1 2021 | -0.33% |
| Q4 2020 | 0.88% |
| Q3 2020 | 2.95% |
| Q2 2020 | 396.16% |
| Q1 2020 | -10.86% |
| Q4 2019 | -9.14% |
| Q3 2019 | -14.31% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | -100.00% |
| Q3 2017 | -49.67% |
| Q2 2017 | 1.34% |
| Q1 2017 | -25.53% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |